Funded Startups in Warren
Across the 9 most recent Warren-area funded entries shown, one disclosed round stands out: Tevogen Bio’s $36M on 2024-05-10 dwarfs the rest of the disclose…
Across the 9 most recent Warren-area funded entries shown, one disclosed round stands out: Tevogen Bio’s $36M on 2024-05-10 dwarfs the rest of the disclosed amounts (the next-largest disclosed figures are Aquestive Therapeutics at $45M on 2023-11-02 and Bellerophon Therapeutics at $5M on 2023-03-06; multiple smaller disclosed rounds cluster at $150K, $50K, $200K, and below). Several entries concentrate in a tight New Jersey window: four of the nine rows list Warren, New Jersey, including Aquestive Therapeutics (2023-11-02, $45M), IO Connect Services (2023-11-01, undisclosed), Tevogen Bio (2024-05-10, $36M), and Bellerophon Therapeutics (2023-03-06, $5M). The schedule also shows a November 2023 burst, with two $10K rounds on 2023-08-23 (Warren, Michigan) and multiple pharma/biotech-related deals spanning 2023-03-06 through the latest 2025-04-17. Disclosed amounts range from $5M (Bellerophon Therapeutics, 2023-03-06) down to $10K (Sticker Blitz and Tech Serve4 U, both 2023-08-23), while “Series Unknown” appears in 8 of 9 rows and one amount is undisclosed (IO Connect Services, 2023-11-01).
Most recent rounds
9 shownRelated listings
Frequently asked
What round size is the outlier in this Warren list, and how does it compare to the next-largest disclosed amounts?
The largest disclosed amount is Aquestive Therapeutics’ $45M on 2023-11-02; it is the only disclosed figure in the tens of millions in this set. The next-largest disclosed amounts are Tevogen Bio at $36M on 2024-05-10 and Bellerophon Therapeutics at $5M on 2023-03-06, so the top two materially outsize every other disclosed deal.
Are there city-specific concentrations, given that “Warren” appears in multiple states here?
Yes. Warren, New Jersey accounts for 4 of the 9 rows (Aquestive Therapeutics on 2023-11-02, IO Connect Services on 2023-11-01, Tevogen Bio on 2024-05-10, and Bellerophon Therapeutics on 2023-03-06), while Warren, Michigan appears in 3 rows (Lakeshore Legal Aid, Sticker Blitz, Tech Serve4 U) and Warren, Ohio appears in 2 rows (REM Electronics, BRITE Energy Innovators).
Which entries fall near the most recent dates in this view (roughly the last 90 days from the latest row)?
Using the latest round date shown (2025-04-17, Lakeshore Legal Aid, $200K), the 90-day window captures only Lakeshore Legal Aid (2025-04-17, $200K) and REM Electronics (2025-04-15, $50K). The next-closest dated row is Tevogen Bio at 2024-05-10, which is well outside that window.
What sector clustering is visible among these 9 companies?
Biotechnology appears in 2 rows (Tevogen Bio on 2024-05-10 at $36M and Bellerophon Therapeutics on 2023-03-06 at $5M), and Health Care appears in 1 row (Aquestive Therapeutics on 2023-11-02 at $45M). The list is otherwise spread across non-overlapping single entries such as Government and Military (Lakeshore Legal Aid, 2025-04-17, $200K) and Energy (BRITE Energy Innovators, 2024-04-11, $150K).
How should an analyst treat stage information here, given the pattern of undisclosed or “Series Unknown”?
Stage is not differentiated: 8 of 9 rows are labeled “Series Unknown,” and one row is “undisclosed” on the amount (IO Connect Services on 2023-11-01). This means comparisons of deal size primarily rely on the disclosed amounts, with IO Connect Services being the only entry where the amount cannot be used in magnitude ranking.
Is there a low-dollar cluster, and which rows anchor the floor of disclosed amounts?
Yes. The smallest disclosed amounts are $10K, tied across two companies on 2023-08-23: Sticker Blitz (Content and Publishing) and Tech Serve4 U (Education), both in Warren, Michigan. Multiple other disclosed rounds sit in the $50K–$200K band (REM Electronics at $50K on 2025-04-15; BRITE Energy Innovators at $150K on 2024-04-11; Lakeshore Legal Aid at $200K on 2025-04-17), separating them from the tens-of-millions outliers.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.